IE000S9YS762 - Common Stock

Overall **LIN** gets a fundamental rating of **5** out of 10. We evaluated **LIN** against 85 industry peers in the **Chemicals** industry. While **LIN** has a great profitability rating, there are some minor concerns on its financial health. **LIN** is valied quite expensively at the moment, while it does show a decent growth rate.

In the past year **LIN** was profitable.

In the past year **LIN** had a positive cash flow from operations.

In the past 5 years **LIN** always reported a positive cash flow from operatings.

The **Return On Assets** of **LIN** (**7.67%**) is better than **80.00%** of its industry peers.

The **Return On Equity** of **LIN** (**15.61%**) is better than **72.94%** of its industry peers.

Looking at the **Return On Invested Capital**, with a value of **8.75%**, **LIN** is in the better half of the industry, outperforming **72.94%** of the companies in the same industry.

The **Average Return On Invested Capital** over the past 3 years for **LIN** is in line with the industry average of **7.57%**.

The last **Return On Invested Capital** (**8.75%**) for **LIN** is above the 3 year average (**7.26%**), which is a sign of increasing profitability.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 7.67% | ||

ROE | 15.61% | ||

ROIC | 8.75% |

ROA(3y)5.86%

ROA(5y)4.61%

ROE(3y)11.55%

ROE(5y)8.92%

ROIC(3y)7.26%

ROIC(5y)5.77%

With an excellent **Profit Margin** value of **18.87%**, **LIN** belongs to the best of the industry, outperforming **92.94%** of the companies in the same industry.

In the last couple of years the **Profit Margin** of **LIN** has declined.

The **Operating Margin** of **LIN** (**24.54%**) is better than **90.59%** of its industry peers.

In the last couple of years the **Operating Margin** of **LIN** has grown nicely.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 24.54% | ||

PM (TTM) | 18.87% | ||

GM | 46.76% |

OM growth 3Y19.39%

OM growth 5Y10.07%

PM growth 3Y27.14%

PM growth 5Y-8.57%

GM growth 3Y2.41%

GM growth 5Y3.59%

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), **LIN** is creating some value.

The number of shares outstanding for **LIN** has been reduced compared to 1 year ago.

The number of shares outstanding for **LIN** has been reduced compared to 5 years ago.

The debt/assets ratio for **LIN** is higher compared to a year ago.

An Altman-Z score of **3.90** indicates that **LIN** is not in any danger for bankruptcy at the moment.

The **Altman-Z score** of **LIN** (**3.90**) is better than **85.88%** of its industry peers.

Looking at the **Debt to FCF ratio**, with a value of **3.51**, **LIN** is in the better half of the industry, outperforming **77.65%** of the companies in the same industry.

A Debt/Equity ratio of **0.46** indicates that **LIN** is not too dependend on debt financing.

The **Debt to Equity ratio** of **LIN** (**0.46**) is comparable to the rest of the industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.46 | ||

Debt/FCF | 3.51 | ||

Altman-Z | 3.9 |

ROIC/WACC1.08

WACC8.11%

A Quick Ratio of **0.67** indicates that **LIN** may have some problems paying its short term obligations.

Looking at the **Quick ratio**, with a value of **0.67**, **LIN** is doing worse than **90.59%** of the companies in the same industry.

The current and quick ratio evaluation for **LIN** is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 0.8 | ||

Quick Ratio | 0.67 |

The **Earnings Per Share** has grown by an nice **15.62%** over the past year.

Measured over the past years, **LIN** shows a quite strong growth in **Earnings Per Share**. The EPS has been growing by **16.48%** on average per year.

Looking at the last year, **LIN** shows a decrease in **Revenue**. The Revenue has decreased by **-1.53%** in the last year.

EPS 1Y (TTM)15.62%

EPS 3Y19.27%

EPS 5Y16.48%

EPS growth Q2Q13.61%

Revenue 1Y (TTM)-1.53%

Revenue growth 3Y6.44%

Revenue growth 5Y17.23%

Revenue growth Q2Q5.1%

Based on estimates for the next years, **LIN** will show a small growth in **Revenue**. The Revenue will grow by **3.99%** on average per year.

EPS Next Y6.52%

EPS Next 2Y10.85%

EPS Next 3Y9.53%

EPS Next 5Y9.24%

Revenue Next Year5.62%

Revenue Next 2Y3.4%

Revenue Next 3Y3.55%

Revenue Next 5Y3.99%

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

Based on the **Price/Earnings** ratio of **30.68**, the valuation of **LIN** can be described as expensive.

When comparing the **Price/Earnings** ratio of **LIN** to the average of the S&P500 Index (**26.18**), we can say **LIN** is valued inline with the index average.

A **Price/Forward Earnings** ratio of **29.28** indicates a quite expensive valuation of **LIN**.

Based on the **Price/Forward Earnings** ratio, **LIN** is valued a bit more expensive than the industry average as 64.71% of the companies are valued more cheaply.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 30.68 | ||

Fwd PE | 29.28 |

69.41% of the companies in the same industry are cheaper than **LIN**, based on the **Enterprise Value to EBITDA** ratio.

The rest of the industry has a similar **Price/Free Cash Flow** ratio as **LIN**.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 38.32 | ||

EV/EBITDA | 18.46 |

The high **PEG Ratio(NY)**, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.

PEG (NY)4.71

PEG (5Y)1.86

EPS Next 2Y10.85%

EPS Next 3Y9.53%

With a **Yearly Dividend Yield** of **1.19%**, **LIN** has a reasonable but not impressive dividend return.

Compared to an average industry **Dividend Yield** of **3.82**, **LIN** has a dividend in line with its industry peers.

With a **Dividend Yield** of **1.19**, **LIN** pays less dividend than the S&P500 average, which is at **2.48**.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.19% |

The dividend of **LIN** is nicely growing with an annual growth rate of **12.68%**!

Dividend Growth(5Y)12.68%

Div Incr Years3

Div Non Decr Years3

The dividend of **LIN** is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.

DP40.04%

EPS Next 2Y10.85%

EPS Next 3Y9.53%

**LINDE PLC**

NASDAQ:LIN (2/20/2024, 9:50:05 AM)

**436.03**

**+4.4 (+1.02%) **

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap211.43B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.19% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 30.68 | ||

Fwd PE | 29.28 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)4.71

PEG (5Y)1.86

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 7.67% | ||

ROE | 15.61% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 24.54% | ||

PM (TTM) | 18.87% | ||

GM | 46.76% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.41

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.46 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 0.8 | ||

Quick Ratio | 0.67 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)15.62%

EPS 3Y19.27%

EPS 5Y

EPS growth Q2Q

EPS Next Y6.52%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-1.53%

Revenue growth 3Y6.44%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y